SecurityVTWG / Vanguard Russell 2000 Growth ETF (92206C623)
Institutional Owners59
Institutional Shares581,941
Institutional Value$ 85,785,000 USD
Related VCIT / Vanguard Intermediate-Term Corporate Bond Index Fund
VGIT / Vanguard Intermediate-Term Government Bond Index Fund
VCLT / Vanguard Long-Term Corporate Bond Index Fund
VGLT / Vanguard Long-Term Government Bond Index Fund
VMBS / Vanguard Mortgage-Backed Securities Index Fund
VONE / Vanguard Russell 1000 ETF
VONG / Vanguard Russell 1000 Growth ETF
VONV / Vanguard Russell 1000 Value ETF
VTWO / Vanguard Russell 2000 ETF
VTWV / Vanguard Russell 2000 Value ETF
VTHR / Vanguard Russell 3000 ETF
VCSH / Vanguard Short-Term Corporate Bond Index Fund
VGSH / Vanguard Short-Term Government Bond Index Fund

Institutional Stock Ownership and Shareholders

VTWG / Vanguard Russell 2000 Growth ETF Institutional Ownership

Vanguard Russell 2000 Growth ETF (NASDAQ:VTWG) has 59 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 581,941 shares. Largest shareholders include Bank Of America Corp /de/, First Allied Advisory Services, Inc., LPL Financial LLC, Morgan Stanley, UBS Group AG, Stordahl Capital Management, Inc., Jane Street Group, Llc, Relaxing Retirement Coach, Susquehanna International Group, Llp, and Brown Advisory Inc.
Vanguard Russell 2000 Growth ETF (NASDAQ:VTWG) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-13 13F-HR IHT Wealth Management, LLC 100 0 -100.00 14 0 -100.00
2018-07-19 13F-HR HUNTINGTON NATIONAL BANK 7 5 -28.57
2018-05-11 13F-HR CITIGROUP INC 655 690 5.34 89 95 6.74
2018-08-14 13F-HR Cetera Advisor Networks LLC 3,053 0 -100.00 424 0 -100.00
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 16,965 5,085 -70.03 2,347 754 -67.87
2018-08-14 13F-HR HighTower Advisors, LLC 12,840 12,667 -1.35 1,775 1,879 5.86
2018-02-15 13F-HR Bb&t Investment Services, Inc. 49 7
2018-08-15 13F-HR JANE STREET GROUP, LLC 0 26,928 0 3,992
2018-08-13 13F-HR Global Retirement Partners, Llc 22 22 0.00 3 3 0.00
2018-08-13 13F-HR Advisor Group, Inc. 305 4,291 1,306.89 42 636 1,414.29
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 3,308 2,992 -9.55 457 443 -3.06
2018-08-03 13F-HR Seacrest Wealth Management, Llc 120 120 0.00 17 18 5.88
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 8,949 9,008 0.66 1,238 1,335 7.84
2018-08-14 13F-HR UBS Group AG 33,912 33,644 -0.79 4,691 4,987 6.31
2018-08-13 13F-HR CAPTRUST FINANCIAL ADVISORS 0 0 0 0
2018-07-24 13F-HR Janney Montgomery Scott LLC 8,040 1,192
2018-07-30 13F-HR/A Virtu Financial LLC 5,358 8,813 64.48 741 1,306 76.25
2018-08-09 13F-HR Sawtooth Asset Management, Inc. 1,801 267
2018-08-14 13F-HR Legacy Financial Strategies, Llc 2,247 3,670 63.33 311 544 74.92
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,286 1,286 0.00 177 177 0.00
2018-08-10 13F-HR PATHSTONE FAMILY OFFICE, LLC 523 386 -26.20 72 57 -20.83
2018-08-10 13F-HR CITIGROUP INC 690 1,020 47.83 95 151 58.95
2018-08-10 13F-HR BROWN ADVISORY INC 18,180 18,180 0.00 2,515 2,695 7.16
2018-08-01 13F-HR COMERICA BANK 5,525 4,957 -10.28 787 762 -3.18
2018-08-13 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 4,215 4,215 0.00 583 625 7.20
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 58,860 100,207 70.25 8,142 14,855 82.45
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 5,372 5,878 9.42 743 871 17.23
2018-08-13 13F-HR ARTHUR M. COHEN & ASSOCIATES, LLC 1,353 201
2017-01-13 13F-HR MetLife Securities, Inc 3,577 5,782 61.64 387 645 66.67
2018-08-07 13F-HR IFP Advisors, Inc 96 96 0.00 13 14 7.69
2018-08-13 13F-HR Claybrook Capital, Llc 382 382 0.00 53 57 7.55
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 438 668 52.51 61 99 62.30
2018-08-14 13F-HR ROYAL BANK OF CANADA 1,857 6,084 227.63 257 902 250.97
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 1,503 0 -100.00 208 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,114 21,030 39.14 2,091 3,117 49.07
2018-07-30 13F-HR Parallel Advisors, LLC 8 8 0.00 1 1 0.00
2018-08-14 13F-HR FLAGSHIP HARBOR ADVISORS, LLC 230 34
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 1,587 1,587 0.00 219 235 7.31
2018-07-09 13F-HR Polaris Wealth Advisers, LLC 50 50 0.00 7 7 0.00
2018-08-03 13F-HR SEI INVESTMENTS CO 104 15
2018-08-10 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1,400 1,400 0.00 194 208 7.22
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 10,985 13,462 22.55 1,520 1,995 31.25
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 15,371 16,381 6.57 2,126 2,428 14.21
2018-04-16 13F-HR IFC Holdings Incorporated/FL 2,322 0 -100.00 316 0 -100.00
2018-09-20 13F-HR Rehmann Capital Advisory Group 104 0 -100.00 14 0 -100.00
2018-08-14 13F-HR SUNTRUST BANKS INC 11,297 13,187 16.73 1,562 1,954 25.10
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-04-18 13F-HR/A FNY Partners Fund LP 148 20
2018-05-15 13F-HR We Are One Seven, Llc 25 25 0.00 3 3 0.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 15,632 14,823 -5.18 1,920 1,925 0.26
2018-08-14 13F-HR LPL Financial LLC 47,232 49,665 5.15 6,533 7,362 12.69
2018-08-10 13F-HR Proficio Capital Partners LLC 3 3 0.00 0 0
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 12,450 12,461 0.09 1,722 1,847 7.26
2018-08-08 13F-HR Hanson McClain, Inc. 153 23
2018-08-14 13F-HR MORGAN STANLEY 46,875 48,839 4.19 6,484 7,240 11.66
2018-08-13 13F-HR BLAIR WILLIAM & CO/IL 1,580 1,580 0.00 219 234 6.85
2018-08-07 13F-HR Relaxing Retirement Coach 34,753 23,659 -31.92 4,808 3,505 -27.10
2018-07-27 13F-HR Eqis Capital Management, Inc. 10,378 9,107 -12.25 1,435 1,350 -5.92
2018-08-08 13F-HR First Allied Advisory Services, Inc. 14,841 51,994 250.34 2,054 7,708 275.27
2018-08-14 13F-HR Centaurus Financial, Inc. 341 51
2018-05-04 13F-HR Financial Gravity Companies, Inc. 59 8
2018-07-25 13F-HR Stordahl Capital Management, Inc. 28,569 29,294 2.54 3,952 4,343 9.89
2018-08-10 13F-HR Amerivest Investment Management LLC 1,280 190
2018-08-14 13F-HR Financial Gravity Wealth, Inc. 59 67 13.56 8 10 25.00
2018-08-14 13F-HR Cetera Advisors LLC 2,549 2,660 4.35 353 394 11.61
2018-08-09 13F-HR BlackRock Inc. 29 29 0.00 4 4 0.00

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

2018-05-16 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the Vanguard Russell 2000 Growth ETF (VTWG - Free Report) , a passively managed exchange traded fund launched on 09/22/2010. (20-0)

Should Vanguard Russell 2000 Growth ETF (VTWG) Be on Your Investing Radar?

2018-04-11 zacks
If you're interested in broad exposure to the Small Cap Growth segment of the US equity market, look no further than the Vanguard Russell 2000 Growth ETF (VTWG - Free Report) , a passively managed exchange traded fund launched on 09/22/2010. (28-0)

CUSIP: 92206C623